Tianjin Huanhu Hospital
Tianjin, Tianjin Municipality, 300070, China
Location status: Recruiting
NCT Number: NCT06090682
This study intends to apply structural and functional brain network neuroimaging techniques combined with image post-processing methods to explore the differences in brain network changes in PD patients with cognitive impairment after DBS or TMS.
Interested in participating?
Request InfoUp to 75 year
All sexes
Observational
Tianjin, Tianjin Municipality, 300070, China
Location status: Recruiting
A variety of post-processing methods (VBM, SPM, CAT, LEAD-DBS, etc.) were used to analyze structural brain network images (sMRI, DTI) and functional brain network images (rs-fMRI, PET) based on connectomics, and combined with the changes of clinical symptoms before and after treatment. To study the mechanism of the influence of neural regulation on brain network, and further analyze how DBS and TMS improve the cognitive symptoms of PD patients from the perspective of brain connectomics, so as to explore the occurrence and development of Parkinson's disease with cognitive impairment and the possible improvement mechanism.According to the individual differences in clinical symptoms of different PD patients, better stimulation sites and the best brain network are sought to further guide the surgical plan, so as to obtain the best clinical treatment effect.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exclusion criteria
included patients with severe cognitive impairment, severe psychiatric disorders, acute levodopa motor response less than 30%, atypical parkinsonism, and contraindications to surgery.
We observed the changes in cognitive function of patients before and after different brain stimulation treatments, and further compared the effects of different brain stimulation treatments on cognitive function of PD patients and the related mechanisms according to whether DBS surgery was performed or TMS therapy was given only according to the surgical indications.
Time frame: December 2023 to December 2026
The Montreal Cognitive Rating Scale was used to assess the overall cognitive status of patients before and after treatment
Time frame: December 2023 to December 2026
VF test was used to assess frontal executive function and related language function
Time frame: December 2023 to December 2026
Measures motor symptoms and Higher scores indicate more severe impairment in motor function
Contact information is provided by the study sponsor or research team.
Feng Keke, doctor
CONTACT
Zhao Guangrui, doctor
CONTACT
Tianjin Huanhu Hospital
Other
Effect and Mechanism of Deep Brain Stimulation and Transcranial Magnetic Stimulation on Parkinson's Disease With Cognitive Impairment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06518824
Basal Ganglia Diseases, Brain Diseases
Vancouver, British Columbia, Canada
View Trial DetailsNCT06596746
Alzheimer Disease, Amyotrophic Lateral Sclerosis
Cassino, Frosinone, Italy
View Trial DetailsNCT05333549
Basal Ganglia Diseases, Brain Diseases
Richmond, Virginia, United States
View Trial DetailsNCT06275633
Basal Ganglia Diseases, Behavior
Copenhagen, Capital Region, Denmark
View Trial Details